“The University of Tennessee’s College of Veterinary Medicine (UTCVM) has a unique opportunity for collaboration with the Cancer Imaging and Tracer Development Research Program (CITDRP) at the University of Tennessee Medical Center. The UTCVM has established a strong collaboration with the CITDRP for the benefit of human and veterinary patients. We will use PET imaging to study cutaneous mast cell tumors (MCT) and canine lymphoma (LSA) in dogs. Whole-body PET scanning is uniquely suited for staging with evaluation of the skin, lymph nodes, spleen and liver for early signs of metastatic spread. All of these sites can be imaged in one non-invasive procedure, using uptake of the 18F-labeled glucose analog 2-deoxy-D-glucose (18FDG), to identify sites of metastasis. The proposed pilot study will evaluate the uptake of 18FDG in 30 tumor-bearing dogs (15 with MCT, 15 with LSA) using PET. All dogs will have their cancer diagnosed and staged using standard imaging techniques and results will be compared with whole-body PET results.”
Celebrating the Breakthroughs Shaping the Future of Canine Health. Meet the 2025 Canine Health Discovery Award Finalists.
Research Program Area
Principal Investigator(s)
Institution
Grant Amount
Sponsor(s)
